Ascites-derived T cells from ovarian cancer patients have been reported to frequently express co-inhibitory receptors [39], which can lead to T cell dysfunction in ovarian cancer [40], and CD4+ T cells expressing the transcription factor FoxP3 usually favor tumor progression [41–43]. This evidence concerns the gene FOXP3 and neoplasm.